Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

Item
http://www.wikidata.org/entity/Q33375088
Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy.Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group.Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients.Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to Carboplatin.Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer.New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer.Oxaliplatin for the treatment of ovarian cancer.A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.
P2860

Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study.

Item
http://www.wikidata.org/entity/Q33375088
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@ast
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@en
type
label
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@ast
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@en
prefLabel
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@ast
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Docetaxel and oxaliplatin in t ...... rian cancer: a phase II study.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921